Once-daily fluticasone propionate in stable asthma: Study on airway inflammation

Journal of Asthma

Volumn 43, Issue 2, 2006, Pages 107-111

  Li, Albert M ^a   Tsang, Tony W T ^a   Chan, Karen ^a   Chan, Dorothy F Y ^a   Sung, Rita Y T ^a   Fok, Tai F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Airway inflammation; Asthma; Fluticasone propionate; Once daily

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; NITRIC OXIDE; PREDNISOLONE; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHIL; EXHALATION; FEMALE; HUMAN; HUMAN CELL; MALE; PATIENT SELECTION; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD; SPIROMETRY; SPUTUM ANALYSIS; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

ADOLESCENT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 33745106872     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900500497990     Document Type: Article

References (31)

1. Geddes DM. Inhaled corticosteroids: benefits and risks. Thorax 1992; 47:404-407.
2. National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. National Asthma Education Program, Highlights of the Expert Panel Report 2. Bethesda, MD: National Institutes of Health, NIH publication 97-4015A, May 1997.
3. Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, Rohr AS. Compliance in clinical trials of nonbronchodilator, anti-asthma medications. Ann Allergy 1991; 66:294-299.
4. Apter AJ, Reisine ST, Affleck G, Barrows E, Zuwallack RL. Adherence with twice-daily dosing of inhaled steroids. Am J Respir Crit Care Med 1998; 157:1810-1817.
5. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: Is there a solution to the problem? Ann Allergy Asthma Immunol 1997; 79:177-185.
6. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98(6 pt 1): 1051-1057.
7. Tashkin DP. Multiple dose regimens. Impact on compliance. Chest 1995; 107:176S-182S.
8. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84(Suppl A):25-29.
9. Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101:S440-S446.
10. Hogger P, Bonsmann U, Rohdewald P. Distribution and intrinsic activity of inhaled corticosteroids in vitro. Eur J Pharm Sci 1994; 59:597-602.
11. Lipworth BJ. Systemic bioavailability of fluticasone proprionate. Br J Clin Pharmacol 2001; 52:457-460.
12. Esmailpour N, Hogger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997; 10:1496-1499.
13. Wolfe I, Rooklin A, Grady J, Monk ZM, Stevens A, Prillaman B, Duke S, Harding S. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by discus device in patients with asthma treated with or without inhaled corticosteroids. J Allergy Clin Immunol 2000; 105:1153-1161.
14. Ayres J, Bateman ED, Lundback B, Harris TA. High dose fluticasone propionate, 1mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J 1995; 8:579-586.
15. Berger WE, Ford LB, Mahr T, Nathan RA, Crim C, Edwards L, Wightman DS, Lincourt WR, Rickard K. Efficacy and safety of fluticasone propionate 250 micrograms administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids. Ann Allergy Asthma Immunol 2002; 89:393-399.
16. Boulet LP, Cowie RL, Negro RD, Brett W, Gold M, Marques A, Thorburn WS, Stepner NM, Robson R. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Can Respir J 2000; 7:239-247.
17. Nathan RA, Li JTC, Finn A, Jones R, Payne E, Wolford JP, Harding SM. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. Chest 2000; 118:296-302.
18. ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. Chest 2000; 118:303-312.
19. Hodges I, Netherway T. Once daily inhaled fluticasone propionate is as effective as twice daily in children with stable mild to moderate asthma (abstract). Thorax 1998; 53(suppl 4).
20. LaForce CF, Pearlmaen DS, Ruff ME, Silvers WS, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 2000; 85:407-415.
21. Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ. Inhaled fluticasone propionate by diskus in the treatment of asthma: A comparison of the efficacy of the same nominal dose given either once or twice a day. Chest 2003; 124:1584-1593.
22. Warner JO. Asthma: A follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67:240-248.
23. Anonymous. Recommendations for standardised procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160:2104-2117.
24. Ip MS, Karlberg EM, Karlberg JP, Luk KD, Leong JC. Lung function reference values in Chinese children and adolescents in Hong Kong. Am J Respir Crit Care Med 2000; 162:424-429.
25. Smith CM, Anderson SD. Inhalational challenge using hypertonic saline in asthmatic subjects: A comparison with responses to hyperpnoea, metacholine and water. Eur Respir J 1990; 3:144-151.
26. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475.
27. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9.
28. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: Induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16:1008-1015.
29. Moller C, Stromberg L, Oldaeus G, Arwestrom E, Kjellman M. Efficacy of once daily administration of budesonide by turbuhaler in children with stable asthma. Pediatr Pulmonol 1999; 28:337-343.
30. Campbell LM, Bodalia B, Gogbashian CA, Gunn SD, Humphreys PJ, Powell JP. Once-daily budesonide: 400 micrograms once daily is effective as 200 micrograms twice daily in controlling childhood asthma. PETITE Research Group. Int J Clin Pract 1998; 52:213-219.
31. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, Follows RM, Tollemar U, Richardson PD. Pulmicort turbuhaler once daily as initial prophylactic therapy for asthma. Respir Med 1994;88:293-299.